Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 79

1.

Clinical significance of CD146 and latexin during different stages of thyroid cancer.

Abd Elmageed ZY, Moroz K, Kandil E.

Mol Cell Biochem. 2013 Sep;381(1-2):95-103. doi: 10.1007/s11010-013-1691-x. Epub 2013 May 28.

PMID:
23712706
2.

Latexin expression is downregulated in human gastric carcinomas and exhibits tumor suppressor potential.

Li Y, Basang Z, Ding H, Lu Z, Ning T, Wei H, Cai H, Ke Y.

BMC Cancer. 2011 Apr 6;11:121. doi: 10.1186/1471-2407-11-121.

3.

DUSP6/MKP3 is overexpressed in papillary and poorly differentiated thyroid carcinoma and contributes to neoplastic properties of thyroid cancer cells.

Degl'Innocenti D, Romeo P, Tarantino E, Sensi M, Cassinelli G, Catalano V, Lanzi C, Perrone F, Pilotti S, Seregni E, Pierotti MA, Greco A, Borrello MG.

Endocr Relat Cancer. 2013 Jan 21;20(1):23-37. doi: 10.1530/ERC-12-0078. Print 2013 Feb.

4.

Aberrant l1 cell adhesion molecule affects tumor behavior and chemosensitivity in anaplastic thyroid carcinoma.

Kim KS, Min JK, Liang ZL, Lee K, Lee JU, Bae KH, Lee MH, Lee SE, Ryu MJ, Kim SJ, Kim YK, Choi MJ, Jo YS, Kim JM, Shong M.

Clin Cancer Res. 2012 Jun 1;18(11):3071-8. doi: 10.1158/1078-0432.CCR-11-2757. Epub 2012 Apr 3.

5.

Expression of cancer stem cell markers is more frequent in anaplastic thyroid carcinoma compared to papillary thyroid carcinoma and is related to adverse clinical outcome.

Yun JY, Kim YA, Choe JY, Min H, Lee KS, Jung Y, Oh S, Kim JE.

J Clin Pathol. 2014 Feb;67(2):125-33. doi: 10.1136/jclinpath-2013-201711. Epub 2013 Aug 28.

PMID:
23986551
6.

Group I p21-activated kinases regulate thyroid cancer cell migration and are overexpressed and activated in thyroid cancer invasion.

McCarty SK, Saji M, Zhang X, Jarjoura D, Fusco A, Vasko VV, Ringel MD.

Endocr Relat Cancer. 2010 Oct 29;17(4):989-99. doi: 10.1677/ERC-10-0168. Print 2010 Dec.

7.

The expression and role of serum response factor in papillary carcinoma of the thyroid.

Kim HJ, Kim KR, Park HS, Jang KY, Chung MJ, Shong M, Moon WS.

Int J Oncol. 2009 Jul;35(1):49-55.

PMID:
19513551
9.

Growth inhibition of thyroid follicular cell-derived cancers by the opioid growth factor (OGF) - opioid growth factor receptor (OGFr) axis.

McLaughlin PJ, Zagon IS, Park SS, Conway A, Donahue RN, Goldenberg D.

BMC Cancer. 2009 Oct 18;9:369. doi: 10.1186/1471-2407-9-369.

10.

Anterior gradient protein 2 promotes survival, migration and invasion of papillary thyroid carcinoma cells.

Di Maro G, Salerno P, Unger K, Orlandella FM, Monaco M, Chiappetta G, Thomas G, Oczko-Wojciechowska M, Masullo M, Jarzab B, Santoro M, Salvatore G.

Mol Cancer. 2014 Jun 30;13:160. doi: 10.1186/1476-4598-13-160.

11.

Loss of the CBX7 gene expression correlates with a highly malignant phenotype in thyroid cancer.

Pallante P, Federico A, Berlingieri MT, Bianco M, Ferraro A, Forzati F, Iaccarino A, Russo M, Pierantoni GM, Leone V, Sacchetti S, Troncone G, Santoro M, Fusco A.

Cancer Res. 2008 Aug 15;68(16):6770-8. doi: 10.1158/0008-5472.CAN-08-0695.

12.

Expression of the melanoma-associated antigen is associated with progression of human thyroid cancer.

Cheng S, Liu W, Mercado M, Ezzat S, Asa SL.

Endocr Relat Cancer. 2009 Jun;16(2):455-66. doi: 10.1677/ERC-09-0002. Epub 2009 Mar 4.

13.

CD146 expression is associated with a poor prognosis in human breast tumors and with enhanced motility in breast cancer cell lines.

Zabouo G, Imbert AM, Jacquemier J, Finetti P, Moreau T, Esterni B, Birnbaum D, Bertucci F, Chabannon C.

Breast Cancer Res. 2009;11(1):R1. doi: 10.1186/bcr2215. Epub 2009 Jan 5.

14.

Expression and clinical significance of FOXE1 in papillary thyroid carcinoma.

Fan Y, Ding Z, Yang Z, Deng X, Kang J, Wu B, Zheng Q.

Mol Med Rep. 2013 Jul;8(1):123-7. doi: 10.3892/mmr.2013.1494. Epub 2013 May 28.

PMID:
23715628
15.

Downregulation of miR-138 is associated with overexpression of human telomerase reverse transcriptase protein in human anaplastic thyroid carcinoma cell lines.

Mitomo S, Maesawa C, Ogasawara S, Iwaya T, Shibazaki M, Yashima-Abo A, Kotani K, Oikawa H, Sakurai E, Izutsu N, Kato K, Komatsu H, Ikeda K, Wakabayashi G, Masuda T.

Cancer Sci. 2008 Feb;99(2):280-6. doi: 10.1111/j.1349-7006.2007.00666.x. Epub 2008 Jan 14.

16.

Tamoxifen inhibits growth, migration, and invasion of human follicular and papillary thyroid cancer cells in vitro and in vivo.

Hoelting T, Siperstein AE, Duh QY, Clark OH.

J Clin Endocrinol Metab. 1995 Jan;80(1):308-13.

PMID:
7829632
17.

[The study of the correlation of papillary thyroid carcinoma's invasion toward Ezrin and E-cadherin].

Liu C, Chen X, Gao Z, Liu Z, Tao X.

Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2012 Sep;26(17):789-91, 795. Chinese.

PMID:
23214316
18.

Activation of the Sonic Hedgehog pathway in thyroid neoplasms and its potential role in tumor cell proliferation.

Xu X, Ding H, Rao G, Arora S, Saclarides CP, Esparaz J, Gattuso P, Solorzano CC, Prinz RA.

Endocr Relat Cancer. 2012 Apr 10;19(2):167-79. doi: 10.1530/ERC-11-0305. Print 2012 Apr.

19.

MUC1 mucin gene, transcripts, and protein in adenomas and papillary carcinomas of the thyroid.

Bièche I, Ruffet E, Zweibaum A, Vildé F, Lidereau R, Franc B.

Thyroid. 1997 Oct;7(5):725-31.

PMID:
9349575
20.

Targeting of the anti-apoptotic gene survivin in human thyroid carcinoma.

Chen Z, Liu N, Zhu G, Dralle H, Hoang-Vu C.

Int J Mol Med. 2012 Sep;30(3):465-72. doi: 10.3892/ijmm.2012.1046. Epub 2012 Jun 28.

Items per page

Supplemental Content

Write to the Help Desk